Cargando…
Assessment and diffusion of medical innovations in France: an overview
Background: In France, a significant part of health expenditure is publicly funding. This put a heavy burden on society. In an economic context requiring tight control of public spending, it seems relevant to control the diffusion of medical innovations. That is why health technology assessment is s...
Autores principales: | Dubromel, Amélie, Geffroy, Loïc, Aulagner, Gilles, Dussart, Claude |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Routledge
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907634/ https://www.ncbi.nlm.nih.gov/pubmed/29686802 http://dx.doi.org/10.1080/20016689.2018.1458575 |
Ejemplares similares
-
Organizational aspect in healthcare decision-making: a literature review
por: Dubromel, Amélie, et al.
Publicado: (2020) -
Multiple criteria decision analysis for therapeutic innovations in a hemophilia care center: A pilot study of the organizational impact of innovation in hemophilia care management
por: Beny, Karen, et al.
Publicado: (2022) -
Epidemiology and Clinical Burden of Meningococcal Disease in France: Scoping Review
por: Baloche, Alexiane, et al.
Publicado: (2023) -
Medico-economic study of pain in an emergency department: a targeted literature review
por: Dussart, Claude, et al.
Publicado: (2019) -
Comparison of health technology assessment for new medicines in France and England: an example based on ixazomib for patients with relapsed or refractory multiple myeloma
por: Armoiry, Xavier, et al.
Publicado: (2019)